Invention Application
- Patent Title: Antiretroviral Drug Targeting Human Endogenous Retrovirus
-
Application No.: US15314017Application Date: 2015-05-27
-
Publication No.: US20170101461A1Publication Date: 2017-04-13
- Inventor: Herve Perron , Francois Curtin , Alois Lang , Raphael Faucard , Julie Medina , Alexandra Madeira , Nadege Gehin
- Applicant: Geneuro SA
- Priority: EP14305806.3 20140528
- International Application: PCT/EP2015/061691 WO 20150527
- Main IPC: C07K16/10
- IPC: C07K16/10 ; C12Q1/70 ; A61K31/7072 ; A61K39/42 ; A61K45/06
Abstract:
The invention relates to an antibody, a fragment or a derivative thereof, for use as an antiretroviral drug targeting a virus belonging to human endogenous retroviruses type W (HERV-W), wherein said antibody, fragment or derivative thereof is directed against HERV-W Envelope protein (HERV-W Env). The invention also relates to a composition comprising said antibody and a retroviral reverse-transcriptase inhibitory drug, for use as an antiretroviral drug targeting a virus belonging to HERV-W.
Information query
